BridgeMD
New treatment option for Beta-Thalassemia
Official title Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
ClinicalTrials.gov ID: NCT06568926
What this study is testing
- What it's testing
- The β-thalassemias are a group of inherited disorders of hemoglobin (Hb) synthesis characterized by chronic anemia of varying severity. The degree of anemia relies on several genetic and environmental factors and determines the need for regular transfusion therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 18
You may be able to join if
- confirmed diagnosis of beta thalassemia major or intermedia,
- Age between 2-18 years,
- Receiving regular blood transfusions every 2-5 weeks
- Prescribed oral iron chelation therapy with deferasirox for at least 1 year prior to enrollment.
You likely can't join if
- Age less than 2 years and more than 18 years
- Any cause of blood transfusion other than beta Thalassemia
- Patients on deferoxamine
The study team makes the final eligibility decision.
Where it's taking place
- Sohag, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sohag, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.